Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. A human tRNA methyltransferase 9-like protein prevents tumour growth by regulating LIN9 and HIF1-α

A human tRNA methyltransferase 9-like protein prevents tumour growth by regulating LIN9 and HIF1-α

Thumbnail Image
Download
Name

Begley-2013-A human tRNA methylt.pdf

Size

1.89 MB

Format

Adobe PDF

Checksum (MD5)

7e463c7c186a7f9632537bf2330cb2bb

Author(s)
Begley, Ulrike
•
Sosa, Maria Soledad
•
Avivar-Valderas, Alvaro
•
Patil, Ashish
•
Endres, Lauren
•
Estrada, Yeriel
•
Chan, Tsz Yan Clement
•
Su, Dan
•
Dedon, Peter C.
•
Aguirre-Ghiso, Julio A.
more
Date Issued
April 2013
Journal
EMBO Molecular Medicine
Publisher
Wiley Blackwell
Citation
Begley, Ulrike, Maria Soledad Sosa, Alvaro Avivar-Valderas, Ashish Patil, Lauren Endres, Yeriel Estrada, Clement T.Y. Chan, et al. “A Human tRNA Methyltransferase 9-Like Protein Prevents Tumour Growth by Regulating LIN9 and HIF1-α.” EMBO Molecular Medicine 5, no. 3 (March 2013): 366–383.
Version
Final published version
Abstract
Emerging evidence points to aberrant regulation of translation as a driver of cell transformation in cancer. Given the direct control of translation by tRNA modifications, tRNA modifying enzymes may function as regulators of cancer progression. Here, we show that a tRNA methyltransferase 9‐like (hTRM9L/KIAA1456) mRNA is down‐regulated in breast, bladder, colorectal, cervix and testicular carcinomas. In the aggressive SW620 and HCT116 colon carcinoma cell lines, hTRM9L is silenced and its re‐expression and methyltransferase activity dramatically suppressed tumour growth in vivo. This growth inhibition was linked to decreased proliferation, senescence‐like G0/G1‐arrest and up‐regulation of the RB interacting protein LIN9. Additionally, SW620 cells re‐expressing hTRM9L did not respond to hypoxia via HIF1‐α‐dependent induction of GLUT1. Importantly, hTRM9L‐negative tumours were highly sensitive to aminoglycoside antibiotics and this was associated with altered tRNA modification levels compared to antibiotic resistant hTRM9L‐expressing SW620 cells. Our study links hTRM9L and tRNA modifications to inhibition of tumour growth via LIN9 and HIF1‐α‐dependent mechanisms. It also suggests that aminoglycoside antibiotics may be useful to treat hTRM9L‐deficient tumours.
MIT Department
Massachusetts Institute of Technology. Center for Environmental Health Sciences
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Chemistry
Terms of Use
Creative Commons Attribution 3.0
http://creativecommons.org/licenses/by/3.0/
Persistent DSpace Link
http://hdl.handle.net/1721.1/88185
DOI of Published Version
https://doi.org/10.1002/emmm.201201161
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.